Covered recipient · General Payments record
JOHN B KOSTIS
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2019–2022
$225,283.92
- Reported across 52 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $89,073.92 | 23 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | $62,973.92 | 13 |
| ABBVIE INC. | $26,100.00 | 10 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2022 201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $1,200.00 | 02/17/2022 | Consulting Fee | Undisputed | 06/30/2026 | 893099337 | CMS |
| ABBVIE INC. | $2,100.00 | 04/20/2022 | Consulting Fee | Undisputed | 06/30/2026 | 893099339 | CMS |
| ABBVIE INC. | $3,300.00 | 04/21/2022 | Consulting Fee | Undisputed | 06/30/2026 | 893099341 | CMS |
| ABBVIE INC. | $600.00 | 04/21/2022 | Consulting Fee | Undisputed | 06/30/2026 | 893099343 | CMS |
| ABBVIE INC. | $3,000.00 | 05/26/2022 | Consulting Fee | Undisputed | 06/30/2026 | 893099345 | CMS |
| ABBVIE INC. | $4,200.00 | 07/05/2022 | Consulting Fee | Undisputed | 06/30/2026 | 893099347 | CMS |
| ABBVIE INC. | $4,200.00 | 08/31/2022 | Consulting Fee | Undisputed | 06/30/2026 | 893099349 | CMS |
| ABBVIE INC. | $2,700.00 | 09/22/2022 | Consulting Fee | Undisputed | 06/30/2026 | 893099351 | CMS |
| ABBVIE INC. | $3,000.00 | 10/26/2022 | Consulting Fee | Undisputed | 06/30/2026 | 893099353 | CMS |
| ABBVIE INC. | $1,800.00 | 11/23/2022 | Consulting Fee | Undisputed | 06/30/2026 | 893099355 | CMS |
| Intercept Pharmaceuticals, Inc. | $9,349.83 | 01/18/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885809 | CMS |
| Intercept Pharmaceuticals, Inc. | $8,249.86 | 02/11/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885833 | CMS |
| Intercept Pharmaceuticals, Inc. | $4,216.60 | 03/14/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885821 | CMS |
| Intercept Pharmaceuticals, Inc. | $7,699.86 | 04/22/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885841 | CMS |
| Intercept Pharmaceuticals, Inc. | $5,866.57 | 05/23/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885825 | CMS |
| Intercept Pharmaceuticals, Inc. | $4,399.92 | 06/02/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885849 | CMS |
| Intercept Pharmaceuticals, Inc. | $5,316.58 | 06/27/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885829 | CMS |
| Intercept Pharmaceuticals, Inc. | $4,216.59 | 08/02/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885845 | CMS |
| Intercept Pharmaceuticals, Inc. | $2,016.63 | 08/29/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885801 | CMS |
| Intercept Pharmaceuticals, Inc. | $5,133.25 | 10/03/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885837 | CMS |
| Intercept Pharmaceuticals, Inc. | $3,849.94 | 11/21/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885813 | CMS |
| Intercept Pharmaceuticals, Inc. | $1,558.31 | 12/05/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885817 | CMS |
| Intercept Pharmaceuticals, Inc. | $1,099.98 | 12/12/2022 | Consulting Fee | Undisputed | 06/30/2026 | 957885805 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.